Previous studies have confirmed that the JAK‐STAT signaling pathway is activated in CKD, especially in diabetic kidney disease (DKD), but JAK2 and STAT3 are the main concerns, and there are few studies on JAK1.49, 50, 51. Here, STAT3 is linked to diabetic kidney disease.